| Kelly Woker, MSN, RN, AGCNS-BC | |
|
7250 Clearvista Dr Ste 200, Indianapolis, IN 46256-4643 | |
| (317) 621-8504 | |
| Not Available |
| Full Name | Kelly Woker |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 7250 Clearvista Dr Ste 200, Indianapolis, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194392787 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | 28150724A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Woker, MSN, RN, AGCNS-BC 7250 Clearvista Dr Ste 200, Indianapolis, IN 46256-4643 Ph: (317) 621-8504 | Kelly Woker, MSN, RN, AGCNS-BC 7250 Clearvista Dr Ste 200, Indianapolis, IN 46256-4643 Ph: (317) 621-8504 |
News Archive
People with diabetes who maintain intensive, low blood sugar levels are significantly less likely to suffer heart attacks and coronary heart disease, new research published today in The Lancet has shown.
Research compiling statistics on injuries from misuse of household cleaning products reiterates a major message for parents: the most important information on the product label is the safety and usage information.
GeneGo announces the release of the first set of tools and content to come out of its industry-FDA MetaTox™ partnership program. The MetaTox partnership is developing a unique comprehensive systems toxicology suite designed for compound safety assessment in chemical and pharmaceutical R&D.
In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment. The researchers say they believe this is the first time that a SSRI (selective serotonin reuptake inhibitor) has been shown to improve key measures of cognition in people with HIV in a controlled study.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
› Verified 6 days ago
Sheryl Ann Terzini, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 7250 Clearvista Drive, Suite 227, Indianapolis, IN 46256 Phone: 317-621-7804 Fax: 317-621-7275 | |
Johnny Valito Toles Sr., LPN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1635 N Arlington Ave, Indianapolis, IN 46218 Phone: 317-353-6000 | |
Megan Zondor, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1701 N Senate Ave, Indianapolis, IN 46202 Phone: 317-847-0991 | |
Jennifer L Dickinson, NP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 720 Eskenazi Ave, Indianapolis, IN 46202 Phone: 317-880-8211 | |
David Beatty, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1001 W 10th St, Indianapolis, IN 46202 Phone: 317-630-8485 | |
Ms. Raenita D Mears, MSN RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1481 W 10th St, Indianapolis, IN 46202 Phone: 317-988-9013 | |
Dr. Alyson Yvonne Keen, PHD, RN, ACNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1701 N Senate Ave, Indianapolis, IN 46202 Phone: 317-341-3060 |